These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 21635153)

  • 1. Plasma protein binding and blood-free concentrations: which studies are needed to develop a drug?
    Pellegatti M; Pagliarusco S; Solazzo L; Colato D
    Expert Opin Drug Metab Toxicol; 2011 Aug; 7(8):1009-20. PubMed ID: 21635153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of blood sampling schedules on protein drug binding in the rat.
    Hulse M; Feldman S; Bruckner JV
    J Pharmacol Exp Ther; 1981 Aug; 218(2):416-20. PubMed ID: 6166741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Drug binding to blood proteins: characteristics, roles and pathophysiological changes].
    Tillement JP; Duché JC; Barré J
    Bull Acad Natl Med; 2006; 190(4-5):935-46; discussion 946-7. PubMed ID: 17195618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of protein binding for the interpretation of serum or plasma drug concentrations.
    Greenblatt DJ; Sellers EM; Koch-Weser J
    J Clin Pharmacol; 1982; 22(5-6):259-63. PubMed ID: 7107972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of unbound volumes of drug distribution in pharmacokinetic calculations.
    Stepensky D
    Eur J Pharm Sci; 2011 Jan; 42(1-2):91-8. PubMed ID: 21050885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High performance affinity chromatography (HPAC) as a high-throughput screening tool in drug discovery to study drug-plasma protein interactions.
    Vuignier K; Guillarme D; Veuthey JL; Carrupt PA; Schappler J
    J Pharm Biomed Anal; 2013 Feb; 74():205-12. PubMed ID: 23245252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Errors in interpretation of data from equilibrium dialysis protein binding experiments.
    Behm HL; Wagner JG
    Res Commun Chem Pathol Pharmacol; 1979 Oct; 26(1):145-60. PubMed ID: 515500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of DBS sampling in combination with LC-MS/MS for pharmacokinetic evaluation of a compound with species-specific blood-to-plasma partitioning.
    Xu G; Chen JS; Phadnis R; Huang T; Uyeda C; Soto M; Stouch B; Wells MC; James CA; Carlson TJ
    Bioanalysis; 2012 Aug; 4(16):2037-47. PubMed ID: 22946919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative pharmacology or pharmacokinetic pharmacodynamic integration should be a vital component in integrative pharmacology.
    Gabrielsson J; Green AR
    J Pharmacol Exp Ther; 2009 Dec; 331(3):767-74. PubMed ID: 19779129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The early estimation of circulating drug metabolites in humans.
    Luffer-Atlas D
    Expert Opin Drug Metab Toxicol; 2012 Aug; 8(8):985-97. PubMed ID: 22681256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rapid pharmacokinetics screening of drug candidates in vitro and in vivo].
    Dong XN; Zhu XX; Meng ZY; Liu JL; Cao YL; Dou GF
    Yao Xue Xue Bao; 2009 Nov; 44(11):1309-12. PubMed ID: 21355332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma protein binding: from discovery to development.
    Bohnert T; Gan LS
    J Pharm Sci; 2013 Sep; 102(9):2953-94. PubMed ID: 23798314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Free plasma drug concentration].
    Durán JA; Abadín JA
    Med Clin (Barc); 1988 Nov; 91(16):618-20. PubMed ID: 3230963
    [No Abstract]   [Full Text] [Related]  

  • 14. On setting the first dose in man: quantitating biotherapeutic drug-target binding through pharmacokinetic and pharmacodynamic models.
    Lowe PJ; Tannenbaum S; Wu K; Lloyd P; Sims J
    Basic Clin Pharmacol Toxicol; 2010 Mar; 106(3):195-209. PubMed ID: 20050847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valproic acid: in vitro plasma protein binding and interaction with phenytoin.
    Cramer JA; Mattson RH
    Ther Drug Monit; 1979; 1(1):105-16. PubMed ID: 121944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacokinetics (second of two parts).
    Greenblatt DJ; Koch-Weser J
    N Engl J Med; 1975 Nov; 293(19):964-70. PubMed ID: 1101062
    [No Abstract]   [Full Text] [Related]  

  • 17. [Determination of protein binding of drugs using equilibrium dialysis. Influence of volume displacement caused by osmotic pressure].
    Lapicque F; Netter P; Monot C; Bannwarth B; Maknassi MS; Royer RJ
    J Pharmacol; 1986; 17(3):295-300. PubMed ID: 3795973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Drug interactions through influencing plasma-protein binding].
    Ohnhaus EE
    Internist (Berl); 1979 May; 20(5):225-8. PubMed ID: 376478
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of microdosing to assess pharmacokinetic linearity in rats using liquid chromatography-tandem mass spectrometry.
    Balani SK; Nagaraja NV; Qian MG; Costa AO; Daniels JS; Yang H; Shimoga PR; Wu JT; Gan LS; Lee FW; Miwa GT
    Drug Metab Dispos; 2006 Mar; 34(3):384-8. PubMed ID: 16326814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of unbound drug concentration and protein-drug binding fraction in plasma.
    Liu Z; Li F; Huang Y
    Biomed Chromatogr; 1999 Jun; 13(4):262-6. PubMed ID: 10416057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.